Phase 1b Trial of BGJ398/BYL719 in Solid Tumors
Public ClinicalTrials.gov record NCT01928459. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase Ib, Open-label Study of Oral BGJ398 in Combination With Oral BYL719 in Adult Patients With Select Advanced Solid Tumors
Study identification
- NCT ID
- NCT01928459
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- BGJ398 Drug
- BYL719 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- Jul 31, 2016
- Completion
- Jul 31, 2016
- Last update posted
- Dec 8, 2020
2013 – 2016
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 | Tampa | Florida | 33612 | — |
| University of Michigan Comprehensive Cancer Center SC | Ann Arbor | Michigan | 48109-0944 | — |
| Karmanos Cancer Institute Dept of Onc | Detroit | Michigan | 48201 | — |
| Washington University School of Medicine Onc Dept | St Louis | Missouri | 63110 | — |
| Memorial Sloan Kettering Cancer Center Onc Dept | New York | New York | 10065 | — |
| Vanderbilt University Medical Center Dept of Onc | Nashville | Tennessee | 37232 | — |
| Cancer Therapy & Research Center / UT Health Science Center SC | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01928459, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01928459 live on ClinicalTrials.gov.